# Sandip Pravin Patel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sandip-pravin-patel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,165 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 56 |
| i10-index | 136 |
| Last Known Institution | University of San Diego |
| OpenAlex ID | https://openalex.org/A5070734531 |
| ORCID iD | 0000-0002-8387-4840 |
| Works | 635 |

## Researcher papers

Showing 12 of 15.

- [Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers](https://scholariq.org/papers/tumor-mutational-burden-as-an-independent-predictor-of-response-to-immunotherapy/)
- [PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy](https://scholariq.org/papers/pd-l1-expression-as-a-predictive-biomarker-in-cancer-immunotherapy/)
- [Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/non-small-cell-lung-cancer-version-3-2022-nccn-clinical-practice-guidelines-in/)
- [RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancerdiagnostic approach](https://scholariq.org/papers/retracted-article-microbiome-analyses-of-blood-and-tissues-suggest/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2021/)
- [NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-1-2020/)
- [Non–Small Cell Lung Cancer, Version 4.2024](https://scholariq.org/papers/non-small-cell-lung-cancer-version-4-2024/)
- [ALKBH5 regulates anti–PD-1 therapy response by modulating lactate and suppressive immune cell accumulation in tumor microenvironment](https://scholariq.org/papers/alkbh5-regulates-anti-pd-1-therapy-response-by-modulating-lactate-and/)
- [Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology](https://scholariq.org/papers/management-of-immunotherapy-related-toxicities-version-1-2019-nccn-clinical/)
- [Pan-cancer analyses reveal cancer-type-specific fungal ecologies and bacteriome interactions](https://scholariq.org/papers/pan-cancer-analyses-reveal-cancer-type-specific-fungal-ecologies-and-bacteriome/)
- [NCCN Guidelines® Insights: Non–Small Cell Lung Cancer, Version 2.2023](https://scholariq.org/papers/nccn-guidelines-insights-non-small-cell-lung-cancer-version-2-2023/)
- [NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020](https://scholariq.org/papers/nccn-guidelines-insights-management-of-immunotherapy-related-toxicities-version/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Researcher university

- [University of San Diego](https://scholariq.org/institutions/university-of-san-diego/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.